The Pharmacology and Therapeutics Advisory Committee (PTAC) today examined evidence to support an application to fund trastuzumab (Herceptin) for early breast cancer. PTAC is a committee of 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback